Pulse Biosciences, Inc.
PLSE· Nasdaq
PLSEPulse Biosciences, Inc.
Filed Mar 16, 2020 · 10-K · 76 days after period end · 0001625101-20-000011
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$13.79M | -$8.95M | -$8.70M | -$2.81M |
| EPS Diluted | -$0.66 | -$0.51 | -$0.53 | -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 16, 2020 · 76 d after period end
